Skip to main content
OpenTrials

Clinical trial condition

Epilepsy, Idiopathic Generalized

Explore clinical trials studying Epilepsy, Idiopathic Generalized. Study availability and eligibility vary by location and protocol.

30 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Epilepsy, Idiopathic Generalized trial results

Completed

Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures

NCT02408549

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +2 more
Locations
  • EP0012 5 Little Rock, Arkansas, United States
  • EP0012 8 Santa Monica, California, United States
  • Ep0012 31 Colorado Springs, Colorado, United States
  • Ep0012 42 Loxahatchee Groves, Florida, United States
View all 87 locations
View Trial Details
Completed

A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

NCT04252846

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +11 more
Locations
  • Sydvestjysk Sygehus Esbjerg Esbjerg, Region Syddanmark, Denmark
  • Hôpital Pontchaillou Rennes, Ille-et-Vilaine, France
  • Hôpital Roger Salengro Lille, Nord, France
  • Centre de consultations Saint-Jean Bâtiment A Cagnes-sur-Mer, France
View all 36 locations
View Trial Details
Completed

CX-8998 for Absence Seizures

NCT03406702

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +6 more
Locations
  • Arkansas Epilepsy Program Little Rock, Arkansas, United States
  • University of Florida Tampa, Florida, United States
  • Bluegrass Epilepsy Research, LLC Lexington, Kentucky, United States
  • Tufts Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

A Study of Fycompa (Perampanel) in Korean Participants

NCT02722590

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +2 more
Locations
  • Chungju, Chungcheong-do, South Korea
  • Wŏnju, Gangwon-do, South Korea
  • Seongnam, Gyeonggji-do, South Korea
  • Jinju, Gyeongsang-do, South Korea
View Trial Details
Completed

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

NCT02408523

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +2 more
Locations
  • Sp0982 028 Alabaster, Alabama, United States
  • Sp0982 005 Little Rock, Arkansas, United States
  • Sp0982 018 Irvine, California, United States
  • Sp0982 008 Santa Monica, California, United States
View all 115 locations
View Trial Details
Completed

Epilepsy Phenome/Genome Project

NCT00552045

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +20 more
Locations
  • University of Alabama at Birmingham, Epilepsy Center, 1719 6th Ave S, CIRC, Ste 312 Birmingham, Alabama, United States
  • Mayo Clinic College of Medicine Arizona Phoenix, Arizona, United States
  • University of California, San Francisco, 400 Parnassus, Room 847 San Francisco, California, United States
  • The Children's Hospital Denver, Colorado, United States
View all 25 locations
View Trial Details
Completed

Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

NCT01118962

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +6 more
Locations
  • 603 Phoenix, Arizona, United States
  • 602 Little Rock, Arkansas, United States
  • 628 Aurora, Colorado, United States
  • 613 Atlanta, Georgia, United States
View all 19 locations
View Trial Details

Related conditions